Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
1(20%)
Results Posted
67%(2 trials)
Terminated
1(20%)

Phase Distribution

Ph not_applicable
5
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
N/ANon-phased studies
5(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(3)
Terminated(1)

Detailed Status

Completed3
Terminated1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
75.0%
Most Advanced
N/A

Trials by Phase

N/A5 (100.0%)

Trials by Status

completed360%
terminated120%
active_not_recruiting120%

Recent Activity

1 active trials
Showing 5 of 5
active_not_recruitingnot_applicable

PCOS & Insulin Resistance Exercise Study

NCT02303470
terminatednot_applicable

Effect of Exercise Training on Physical, Cognitive, and Behavioral Function in People With TBI

NCT02504866
completednot_applicable

Biochemical Changes in Blood Plasma After Intense Physical Exercise of Healthy Volunteers

NCT05790772
completednot_applicable

Physical Exercise and Energy Balance

NCT03138187
completednot_applicable

Study in Parkinson's Disease of Exercise

NCT01506479

Clinical Trials (5)

Showing 5 of 5 trials
NCT02303470Not Applicable

PCOS & Insulin Resistance Exercise Study

Active Not Recruiting
NCT02504866Not Applicable

Effect of Exercise Training on Physical, Cognitive, and Behavioral Function in People With TBI

Terminated
NCT05790772Not Applicable

Biochemical Changes in Blood Plasma After Intense Physical Exercise of Healthy Volunteers

Completed
NCT03138187Not Applicable

Physical Exercise and Energy Balance

Completed
NCT01506479Not Applicable

Study in Parkinson's Disease of Exercise

Completed

All 5 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
5